Search

Agilent Technologies Inc

Open

BrancheGesundheitswesen

132.87 1.95

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

124.35

Max

134.58

Schlüsselkennzahlen

By Trading Economics

Einkommen

34M

339M

Verkäufe

37M

1.8B

KGV

Branchendurchschnitt

26.368

62.58

EPS

1.49

Dividendenrendite

0.77

Gewinnspanne

18.474

Angestellte

18,000

EBITDA

44M

500M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+16.76% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.77%

2.19%

Nächstes Ergebnis

26. Aug. 2026

Nächste Dividendenausschüttung

22. Juli 2026

Nächstes Ex-Dividendendatum

29. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

4.3B

37B

Vorheriger Eröffnungskurs

130.92

Vorheriger Schlusskurs

132.87

Nachrichtenstimmung

By Acuity

93%

7%

321 / 340 Ranking in Healthcare

Agilent Technologies Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Juli 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20. Juli 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Peer-Vergleich

Kursveränderung

Agilent Technologies Inc Prognose

Kursziel

By TipRanks

16.76% Vorteil

12-Monats-Prognose

Durchschnitt 155.13 USD  16.76%

Hoch 180 USD

Tief 135 USD

Basierend auf 16 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Agilent Technologies Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

16 ratings

13

Buy

3

Halten

0

Sell

Stimmung

By Acuity

321 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
help-icon Live chat